Menopausal Hot Flashes Treatment Market Size, Share & Forecast 2028

Summary

Report Description

Global Menopausal Hot Flashes Treatment market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the increasing technological advancements in products with alternative administration modes. Similarly, a rapid increase in clinical trials by healthcare companies in non-hormonal products is further expected to boost market growth during the forecast period. Moreover, a rapid increase in the number of elderly women across the globe is expected to increase the menopausal hot flashes symptoms. This in turn is expected to create significant growth over the years. Moreover, increasing awareness about women’s health on the back of public as well as private initiatives may fuel the growth of the market over the years. According to the study "Frequent hot flashes in women, 40 to 65 years of age with metabolic syndrome" published in December 2020, women over the age of 40 are more likely to have a fever, about 55.83%, and appear to be associated with metabolic syndrome. Growing focus on research and development of hot flashes is also driving the growth of the market.

Growing Incidences of Menopausal Hot Flashes

The growing incidence of menopausal hot flashes due to consumption of alcohol, smoking, and junk foods is further boost the market growth during the forecast period. Also, growing approval for new treatments along with growing awareness about new menopausal hot flashes treatments will drive the market growth over the years. Hot flashes occur in approximately 75 to 80% of menopausal women in the United States every year. It’s a quick sensation of warmth that basically affects the chest, neck, and face also some of the main factors which are expected to drive the market growth. high prevalence of fluctuating oestrogen levels and deteriorating musculoskeletal health among the women population. Moreover, new market players are investing in the development of new treatments which will further boost the market growth during the forecast period. 73% of women among the women population have post menopausal hot flashes due to fatigue, reduced cognitive function, sleep difficulties, and lowering their quality of life along with growing usage of medical resources which will further demand menopausal hot flashes treatment during the forecast period. As many as 85% of perimenopausal women experience hot flashes (flushes), night sweats, and/or sleep disturbances secondary to vasomotor instability.

Download Free Sample Report

Growing Innovation in Medicine

Growing innovation in medicine for the treatment of menopausal hot flashes along with major companies are focusing on the development of new devices which will help women with menopausal hot flashes syndrome. Companies are developing a new device that reduces menopausal hot flashes. For instance, Menopod instant cooling devices, when applied to the neck help alleviate the severity of hot flashes and it is a portable, quick USB charging device. These smartwatch-like devices used as personal thermostats for women is further expected to boost the market growth during the forecast period. Moreover, companies are investing in the development of customizable mattresses that offer cooling and heating temperature controls which will further boost the market growth during the forecast period. There were an estimated 50 million postmenopausal women in the United States in 2010. According to Meno Martha International Menopause Directory, about 45 million of them were aged older than 52 years, the average age of natural menopause in the Western world. In 2020, the number of women aged more than 51 years was estimated to cross 50 million in United States.

Market Segmentation

Global Menopausal Hot Flashes Treatment market can be segmented on the basis of type, treatment type, distribution channel, and by region. Based on type, the market can be further bifurcated into oral liquid and pill. Based on treatment type, the market can be further divided into hormonal treatment, non-hormonal treatment, and alternative treatment. Based on distribution channels, the market is further split into hospital pharmacies, retail pharmacies, and online pharmacies. On the basis of region, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. On the basis of countries, the United States dominated the global Menopausal Hot Flashes Treatment market on account of the increasing number of women reaching menopausal age.

Recent Development

The U.S. Food and Drug Administration received a new drug application (NDA) for fezolinetant from Astellas Pharma Inc. in June 2022. (FDA). For the treatment of mild to severe vasomotor symptoms (VMS) related to menopause, the experimental oral, nonhormonal chemical fezolinetant is awaiting for approval.
In February 2021, Astellas Pharma Inc. announced the positive results from the Phase 3 pivotal SKYLIGHT 1 and SKYLIGHT 2 clinical trials or fezolinetant, which is an oral, non-hormonal compound being tested for the treatment of moderate to severe vasomotor symptoms (VMS).
In January 2020, Bayer AG strengthened its drug discovery platform through acquisition of Vividion Therapeutics. Vividion Therapeutics produces a variety of small molecule therapies across indications and their initial focus was on targets relevant to oncology and immunology.

Market Players

Abbvie, Inc., Allergan PLC., Bayer AG., Cipla, Inc., Eli Lilly and Company, Emcure Pharmaceuticals Ltd., GSK PLC., Glenmark Pharmaceuticals Ltd., Hisamitsu Pharmaceutical Co. Inc., Merck & Co. Inc. , Novartis Ag., Novo Nordisk AS., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and TherapeuticsMD, Inc. are some of the leading players operating in the Global Menopausal Hot Flashes Treatment Market.

Attribute	Details
Base Year	2022
Historic Data	2018 – 2021
Estimated Year	2023
Forecast Period	2024 – 2028
Quantitative Units	Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028
Report Coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments Covered	By Type By Treatment Type By Distribution Channel By Region
Regional scope	North America, Europe, Asia Pacific, South America, Middle East & Africa
Country scope	United States, Canada, Mexico, France, Germany, United Kingdom, Italy, Spain, China, India, Japan, South Korea, Australia, Brazil, Argentina, Colombia, South Africa, Saudi Arabia, UAE
Key companies profiled	Abbvie, Inc., Allergan PLC., Bayer Ag., Cipla, Inc., Eli Lilly and Company, Emcure Pharmaceuticals Ltd., GSK PLC., Glenmark Pharmaceuticals Ltd., Hisamitsu Pharmaceutical Co. Inc., Merck & Co. Inc. , Novartis Ag., Novo Nordisk AS., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., TherapeuticsMD, Inc.
Customization scope	10% free report customization with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, the global Menopausal Hot Flashes Treatment market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Menopausal Hot Flashes Treatment Market, By Type:

o Oral Liquid

o Pill

Menopausal Hot Flashes Treatment Market, By Treatment Type:

o Hormonal Treatment

o Non-Hormonal Treatment

o Alternative Treatment

Menopausal Hot Flashes Treatment Market, By Distribution Channel:

o Hospital Pharmacies

o Retail Pharmacies

o Online Pharmacies

Menopausal Hot Flashes Treatment Market, By Region:

o North America

United States
Canada
Mexico

o Europe

France
Germany
United Kingdom
Italy
Spain

o Asia Pacific

China
India
Japan
South Korea
Australia

o South America

Brazil
Argentina
Colombia

o Middle East & Africa

South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Menopausal Hot Flashes Treatment Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Menopausal Hot Flashes Treatment Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Menopausal Hot Flashes Treatment Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Type (Oral Liquid v/s Pill)

5.2.2. By Treatment Type (Hormonal Treatment, Non-Hormonal Treatment, Alternative Treatment)

5.2.2.1 Hormonal Treatment (Oestrogen, Oestrogen-Progesterone Combination, Progesterone)

5.2.2.2 Non-Hormonal Treatment (Clonidine, Gabapentin, Pregabalin, Brisdelle, Antidepressants)

5.2.2.3 Alternative Treatment (Vitamin E, Herbal Medicines, Black Cohosh)

5.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)

5.2.4. By Region

5.2.5. By Company (2022)

5.3. Product Map

6. North America Menopausal Hot Flashes Treatment Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Type (Oral Liquid v/s Pill)

6.2.2. By Treatment Type (Hormonal Treatment, Non-Hormonal Treatment, Alternative Treatment)

6.2.2.1 Hormonal Treatment (Oestrogen, Oestrogen-Progesterone Combination, Progesterone)

6.2.2.2 Non-Hormonal Treatment (Clonidine, Gabapentin, Pregabalin, Brisdelle, Antidepressants)

6.2.2.3 Alternative Treatment (Vitamin E, Herbal Medicines, Black Cohosh)

6.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)

6.2.4. By Country

6.3. North America: Country Analysis

6.3.1. United States Menopausal Hot Flashes Treatment Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Type

6.3.1.2.2. Ny Treatment Type

6.3.1.2.3. By Distribution Channel

6.3.2. Canada Menopausal Hot Flashes Treatment Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Type

6.3.2.2.2. Ny Treatment Type

6.3.2.2.3. By Distribution Channel

6.3.3. Mexico Menopausal Hot Flashes Treatment Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Type

6.3.3.2.2. Ny Treatment Type

6.3.3.2.3. By Distribution Channel

7. Europe Menopausal Hot Flashes Treatment Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Type (Oral Liquid v/s Pill)

7.2.2. By Treatment Type (Hormonal Treatment, Non-Hormonal Treatment, Alternative Treatment)

7.2.2.1 Hormonal Treatment (Oestrogen, Oestrogen-Progesterone Combination, Progesterone)

7.2.2.2 Non-Hormonal Treatment (Clonidine, Gabapentin, Pregabalin, Brisdelle, Antidepressants)

7.2.2.3 Alternative Treatment (Vitamin E, Herbal Medicines, Black Cohosh)

7.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)

7.2.4. By Country

7.3. Europe: Country Analysis

7.3.1. France Menopausal Hot Flashes Treatment Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Type

7.3.1.2.2. Ny Treatment Type

7.3.1.2.3. By Distribution Channel

7.3.2. Germany Menopausal Hot Flashes Treatment Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Type

7.3.2.2.2. Ny Treatment Type

7.3.2.2.3. By Distribution Channel

7.3.3. United Kingdom Menopausal Hot Flashes Treatment Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Type

7.3.3.2.2. Ny Treatment Type

7.3.3.2.3. By Distribution Channel

7.3.4. Italy Menopausal Hot Flashes Treatment Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Type

7.3.4.2.2. Ny Treatment Type

7.3.4.2.3. By Distribution Channel

7.3.5. Spain Menopausal Hot Flashes Treatment Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Type

7.3.5.2.2. Ny Treatment Type

7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Menopausal Hot Flashes Treatment Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Type (Oral Liquid v/s Pill)

8.2.2. By Treatment Type (Hormonal Treatment, Non-Hormonal Treatment, Alternative Treatment)

8.2.2.1 Hormonal Treatment (Oestrogen, Oestrogen-Progesterone Combination, Progesterone)

8.2.2.2 Non-Hormonal Treatment (Clonidine, Gabapentin, Pregabalin, Brisdelle, Antidepressants)

8.2.2.3 Alternative Treatment (Vitamin E, Herbal Medicines, Black Cohosh)

8.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)

8.2.4. By Country

8.3. Asia-Pacific: Country Analysis

8.3.1. China Menopausal Hot Flashes Treatment Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Type

8.3.1.2.2. Ny Treatment Type

8.3.1.2.3. By Distribution Channel

8.3.2. India Menopausal Hot Flashes Treatment Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Type

8.3.2.2.2. Ny Treatment Type

8.3.2.2.3. By Distribution Channel

8.3.3. Japan Menopausal Hot Flashes Treatment Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Type

8.3.3.2.2. Ny Treatment Type

8.3.3.2.3. By Distribution Channel

8.3.4. South Korea Menopausal Hot Flashes Treatment Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Type

8.3.4.2.2. Ny Treatment Type

8.3.4.2.3. By Distribution Channel

8.3.5. Australia Menopausal Hot Flashes Treatment Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Type

8.3.5.2.2. Ny Treatment Type

8.3.5.2.3. By Distribution Channel

9. South America Menopausal Hot Flashes Treatment Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Type (Oral Liquid v/s Pill)

9.2.2. By Treatment Type (Hormonal Treatment, Non-Hormonal Treatment, Alternative Treatment)

9.2.2.1 Hormonal Treatment (Oestrogen, Oestrogen-Progesterone Combination, Progesterone)

9.2.2.2 Non-Hormonal Treatment (Clonidine, Gabapentin, Pregabalin, Brisdelle, Antidepressants)

9.2.2.3 Alternative Treatment (Vitamin E, Herbal Medicines, Black Cohosh)

9.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)

9.2.4. By Country

9.3. South America: Country Analysis

9.3.1. Brazil Menopausal Hot Flashes Treatment Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Type

9.3.1.2.2. Ny Treatment Type

9.3.1.2.3. By Distribution Channel

9.3.2. Argentina Menopausal Hot Flashes Treatment Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Type

9.3.2.2.2. Ny Treatment Type

9.3.2.2.3. By Distribution Channel

9.3.3. Colombia Menopausal Hot Flashes Treatment Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Type

9.3.3.2.2. Ny Treatment Type

9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Menopausal Hot Flashes Treatment Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Type (Oral Liquid v/s Pill)

10.2.2. By Treatment Type (Hormonal Treatment, Non-Hormonal Treatment, Alternative Treatment)

10.2.2.1 Hormonal Treatment (Oestrogen, Oestrogen-Progesterone Combination, Progesterone)

10.2.2.2 Non-Hormonal Treatment (Clonidine, Gabapentin, Pregabalin, Brisdelle, Antidepressants)

10.2.2.3 Alternative Treatment (Vitamin E, Herbal Medicines, Black Cohosh)

10.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)

10.2.4. By Country

10.3. MEA: Country Analysis

10.3.1. South Africa Menopausal Hot Flashes Treatment Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Type

10.3.1.2.2. Ny Treatment Type

10.3.1.2.3. By Distribution Channel

10.3.2. Saudi Arabia Menopausal Hot Flashes Treatment Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Type

10.3.2.2.2. Ny Treatment Type

10.3.2.2.3. By Distribution Channel

10.3.3. UAE Menopausal Hot Flashes Treatment Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Type

10.3.3.2.2. Ny Treatment Type

10.3.3.2.3. By Distribution Channel

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development

12.2. Mergers & Acquisitions

12.3. Product Launches

13. Global Menopausal Hot Flashes Treatment Market: SWOT Analysis

14. Porter’s Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Business Overview

15.2. Product Offerings

15.3. Recent Developments

15.4. Financials (As Reported)

15.5. Key Personnel

15.6. SWOT Analysis

18.6.1 Abbvie, Inc.

18.6.2 Allergan PLC.

18.6.3 Bayer Ag.

18.6.4 Cipla, Inc.

18.6.5 Eli Lilly and Company.

18.6.6 Emcure Pharmaceuticals Ltd.

18.6.7 GSK PLC.

18.6.8 Glenmark Pharmaceuticals Ltd.

18.6.9 Hisamitsu Pharmaceutical Co. Inc.

18.6.10 Merck & Co. Inc.

18.6.11 Novartis Ag.

18.6.12 Novo Nordisk AS.

18.6.13 Pfizer, Inc.

18.6.14 Teva Pharmaceutical Industries Ltd.

18.6.15 TherapeuticsMD, Inc.

17. Strategic Recommendations

Figures and Tables

Frequently asked questions

What are the major drivers for the Global Menopausal Hot Flashes Treatment Market?

The rising women geriatric population along with the growing demand for menopausal hot flashes medications due to the increasing incidence of these symptoms are some of the major factors driving the growth of the global Menopausal Hot Flashes Treatment market.

Which are the top players operating in the Global Menopausal Hot Flashes Treatment Market?

Abbvie, Inc., Allergan PLC., Bayer Ag., Cipla, Inc., Eli Lilly and Company, Emcure Pharmaceuticals Ltd., GSK PLC., Glenmark Pharmaceuticals Ltd., Hisamitsu Pharmaceutical Co. Inc., Merck & Co. Inc., Novartis Ag., Novo Nordisk AS., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., TherapeuticsMD, Inc. are some of the leading players operating in the Global Menopausal Hot Flashes Treatment Market.

Which treatment type is expected to dominate the Global Menopausal Hot Flashes Treatment Market during the forecast period?

Hormonal Treatment Type is expected to dominate the global surgical instruments tracking devices market during the forecast period.

Which region is expected to account for the largest share in the Global Menopausal Hot Flashes Treatment Market?

North America is expected to account for the largest share of the Global Menopausal Hot Flashes Treatment Market.

Related Reports

Sakshi Bajaal

Business Consultant

Talk To Analyst

Press Release

Lewy Boy Dementia Treatment Market to Grow at 5.98% CAGR through 2029F

Jun, 2024

Advancements in diagnostic technologies and growing research investments is expected to drive the Global Lewy Boy Dementia Treatment Market growth in the forecast period, 2025-2029.

Buy Now